Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Seminars in Radiation Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/SRAO.2002.31361PMID 11917282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer.

  2001cited by this paper
• Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.

  2000cited by this paper
• A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.

  1999cited by this paper
• 18 Randomized phase III trial of radiation ± amifostine in patients with advanced stage lung cancer

  1999cited by this paper
• Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.

  1999cited by this paper
• Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.

  1998cited by this paper
• Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer.

  1998cited by this paper
• Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.

  1998cited by this paper
• Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study.

  1998cited by this paper
• Therapy and prophylaxis of acute and late radiation-induced sequelae of the esophagus.

  1998cited by this paper
• Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis.

  1997cited by this paper
• Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

  1996cited by this paper
• Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.

  1994cited by this paper
• Use of radiation with or without WR‐2721 in advanced rectal cancer

  1992cited by this paper
• Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.

  1980cited by this paper

• Radiation Modifiers.

  2019cites this paper
• A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

  2017cites this paper
• Radioprotection as a Method to Enhance the Therapeutic Ratio of Radiotherapy

  2017cites this paper
• Potential of Amifostine for Chemoradiotherapy and Radiotherapy-associated Toxicity Reduction in Advanced NSCLC: A Meta-Analysis.

  2016cites this paper
• Radiation-induced esophagitis in lung cancer

  2016cites this paper
• Supportive Therapie in der Radioonkologie

  2015cites this paper
• Ajith TA, Janardhanan KK. Antimutagenic effect of Phellinus rimosus (Berk) Pilat against chemical induced mutations of histidine dependent Salmonella typhimurium strains. Food Chem Toxic 2011; 49: 2676-2680. Ajith TA, Janardhanan KK. Chemopreventive activity of a macrfungus Phellinus rimosus against

  2014cites this paper
• Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician.

  2014cites this paper
• Pharmacology of iron transport.

  2013cites this paper
• Esophagitis, treatment-related toxicity in non-small cell lung cancer.

  2012cites this paper
• Radiation Therapy-Related Toxicity: Esophagus

  2011cites this paper
• Zebrafish as a Model System to Screen Radiation Modifiers

  2007cites this paper
• Amifostine in the management of radiation-induced and chemo-induced mucositis

  2006cites this paper
• Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical trial.

  2005cites this paper
• Treatment-related esophagitis.

  2005cites this paper
• Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.

  2005cites this paper
• Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk.

  2004cites this paper
• Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.

  2004cites this paper
• Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

  2003cites this paper
• Radioprotective effect of amifostine in radiation pneumonitis.

  2003cites this paper
• Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer.

  2003cites this paper
• Effects of dose and schedule on the efficacy of ethyol: preclinical studies.

  2003cites this paper
• A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings.

  2002cites this paper